Kiniksa Pharmaceuticals International, plc 2026 Q1 - Results - Earnings Call Presentation
Corroborated by 2 sources from 2 publishers
TL;DR
Reports differ across sources; according to finance.yahoo.com, kiniksa Pharmaceuticals International (NASDAQ:KNSA) reported first-quarter 2026 results and provided updates on commercial execution for ARCALYST and progress across its clinical pipeline, including KPL-387 and KPL-1161.
Sources
1
Yahoo Finance News
https://finance.yahoo.com/sectors/healthcare/articles/kiniksa-pharmaceuticals-international-q1-earnings-152903822.html
2
Seeking Alpha Market News
https://seekingalpha.com/article/4895195-kiniksa-pharmaceuticals-international-plc-2026-q1-results-earnings-call-presentation?source=feed_all_articles
3
Seeking Alpha Market News
https://seekingalpha.com/article/4895361-kiniksa-pharmaceuticals-international-plc-knsa-q1-2026-earnings-call-transcript?source=feed_all_articles